<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Phys Ther Sci</journal-id><journal-id journal-id-type="iso-abbrev">J Phys Ther Sci</journal-id><journal-id journal-id-type="publisher-id">JPTS</journal-id><journal-title-group><journal-title>Journal of Physical Therapy Science</journal-title></journal-title-group><issn pub-type="ppub">0915-5287</issn><issn pub-type="epub">2187-5626</issn><publisher><publisher-name>The Society of Physical Therapy Science</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26834345</article-id><article-id pub-id-type="pmc">4713784</article-id><article-id pub-id-type="publisher-id">jpts-2015-612</article-id><article-id pub-id-type="doi">10.1589/jpts.27.3755</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Comparison of the effectiveness of local corticosteroid injection and
extracorporeal shock wave therapy in patients with lateral epicondylitis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Beyazal</surname><given-names>M&#x000fc;nevver Serdaro&#x0011f;lu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref rid="cor1" ref-type="corresp"><sup>*</sup></xref></contrib><contrib contrib-type="author"><name><surname>Devrimsel</surname><given-names>G&#x000fc;l</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><aff id="aff1"><label>1)</label> Department of Physical Medicine and Rehabilitation, School
of Medicine, Recep Tayyip Erdo&#x0011f;an University, Turkey</aff></contrib-group><author-notes><corresp id="cor1"><label>*</label>Corresponding author. M&#x000fc;nevver Serdaro&#x0011f;lu Beyazal, Department of Physical Medicine and Rehabilitation, School
of Medicine, Recep Tayyip Erdo&#x0011f;an University: 53100 Rize, Turkey.
(E-mail: <email xlink:href="drmunser@yahoo.com">drmunser@yahoo.com</email>)</corresp></author-notes><pub-date pub-type="epub"><day>28</day><month>12</month><year>2015</year></pub-date><pub-date pub-type="ppub"><month>12</month><year>2015</year></pub-date><volume>27</volume><issue>12</issue><fpage>3755</fpage><lpage>3758</lpage><history><date date-type="received"><day>29</day><month>7</month><year>2015</year></date><date date-type="accepted"><day>17</day><month>9</month><year>2015</year></date></history><permissions><copyright-statement>2015&#x000a9;by the Society of Physical Therapy Science. Published by IPEC
Inc.</copyright-statement><copyright-year>2015</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/"><license-p>This is an open-access article distributed under the terms of the Creative
Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License. </license-p></license></permissions><abstract><p>[Purpose] This study aimed to determine and compare the effectiveness of extracorporeal
shock wave therapy and local corticosteroid injection in patients with lateral
epicondylitis. [Subjects and Methods] Sixty-four patients with lateral epicondylitis were
randomly divided into extracorporeal shock wave therapy and steroid injection groups.
Patients were evaluated using hand grip strength, visual analog scale, and short-form
McGill pain questionnaire at baseline and at 4 and 12 weeks post-treatment. [Results] Both
groups showed statistically significant increase in hand grip strength and decreases on
the visual analog scale and short form McGill pain questionnaire overtime. There was no
statistically significant difference in the percentage of improvement in hand grip
strength and on the short-form McGill pain questionnaire between groups at 4 weeks
post-treatment, whereas the extracorporeal shock wave therapy group showed better results
on the visual analog scale. The percentages of improvements in all 3 parameters were
higher in the extracorporeal shock wave therapy group than in the injection group at 12
weeks post-treatment. [Conclusion] Both the extracorporeal shock wave therapy and steroid
injection were safe and effective in the treatment of lateral epicondylitis. However,
extracorporeal shock wave therapy demonstrated better outcomes than steroid injection at
the long-term follow-up.</p></abstract><kwd-group><title>Key words</title><kwd>Lateral epicondylitis</kwd><kwd>Corticosteroid injection</kwd><kwd>Extracorporeal shock wave therapy</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="s1"><title>INTRODUCTION</title><p>Lateral epicondylitis (LE) is a common musculoskeletal condition that affects 1&#x02013;3% of the
adult population and 2% and 23% of the working population<xref rid="r1" ref-type="bibr">1</xref><sup>)</sup>. Males and females are affected equally, and it commonly presents
between the ages of 35 and 50 years<xref rid="r2" ref-type="bibr">2</xref><sup>)</sup>. The
tendinous origin of the extensor carpi radialis brevis is the area of the most pathologic
change. Overuse or repetitive trauma in this area causes fibrosis and microtears in the
involved tissues<xref rid="r3" ref-type="bibr">3</xref><sup>)</sup>. Elbow pain is the
presenting complaint in patients with epicondylitis. Tenderness on palpation of the lateral
epicondyle and origin of the wrist extensor muscles is suggestive of LE<xref rid="r4" ref-type="bibr">4</xref><sup>)</sup>.</p><p>The primary goals of LE treatment are reduction in pain, preservation of motion,
flexibility, and strength, and improved endurance<xref rid="r5" ref-type="bibr">5</xref><sup>)</sup>. Nonoperative management is the keystone of LE treatment, with
improvement reported in up to 95% of the cases. Physical therapy, activity modification,
nonsteroidal anti-inflammatory drugs, and injections are the primary nonoperative
modalities<xref rid="r6" ref-type="bibr">6</xref><sup>)</sup>. A recent systematic review
and meta-analysis revealed that beyond 8 weeks, the glucocorticoid injection was no more
effective than placebo<xref rid="r7" ref-type="bibr">7</xref><sup>)</sup>.</p><p>Extracorporeal shock wave therapy (ESWT) has been used in the treatment of LE that is
refractory to conservative treatment<xref rid="r4" ref-type="bibr">4</xref><sup>)</sup>. In
ESWT, extracorporeal shockwaves are applied to lesions to help revascularization and
stimulate or reactivate the process of connective tissue and bone healing, thereby relieving
pain and improving function<xref rid="r8" ref-type="bibr">8</xref><sup>)</sup>. There are
conflicting reports in the literature regarding the effectiveness of ESWT in LE. Although
some studies have reported significant improvement in hand grip strength (HGS), pain score,
and functional score after ESWT<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r10" ref-type="bibr">10</xref>,<xref rid="r11" ref-type="bibr">11</xref><sup>)</sup>, a recent
systematic review of ESWT revealed platinum level evidence for little to no benefit from
this procedure in the treatment of lateral elbow pain<xref rid="r12" ref-type="bibr">12</xref><sup>)</sup>.</p><p>This study aimed to determine and compare the effectiveness of ESWT and steroid injection
treatment in patients with LE.</p></sec><sec sec-type="methods" id="s2"><title>SUBJECTS AND METHODS</title><p>This study was approved by the local ethics committee of our institution and performed in
accordance with the principles stated in the 1975 Declaration of Helsinki. All patients
provided written informed consent prior to participation. Sixty-four consecutive patients
(54 females and 10 males, age range 26&#x02013;57&#x02005;years) diagnosed with LE, who were admitted to our
outpatient physical medicine and rehabilitation clinic, were included in this study. The
diagnosis of LE, which was defined as elbow pain that is maximal over the lateral
epicondyle, increases with pressure on the lateral epicondyle, and resists dorsiflexion of
the wrist and/or middle finger, was based on a detailed physical examination<xref rid="r13" ref-type="bibr">13</xref><sup>)</sup>. Patients were excluded if they had a
history of cervical radiculopathy, corticosteroid treatment, or physical therapy in the past
6 months, hand or elbow deformity, or metabolic, inflammatory, or neuromuscular
diseases.</p><p>Sociodemographic characteristics of patients including age, gender, weight, height, body
mass index (BMI), duration of elbow symptoms, and side of involvement were recorded. The
patients were randomly divided into ESWT (n=32) and local corticosteroid injection (n=32)
groups, and were evaluated at baseline and at 4 and 12 weeks post-treatment. Patient
evaluation included measurement of HGS, assessment of pain intensity, and administration of
the short-form McGill pain questionnaire (SF-MPQ)<xref rid="r14" ref-type="bibr">14</xref>,
<xref rid="r15" ref-type="bibr">15</xref><sup>)</sup>. Pain intensity was evaluated using
a 10-cm horizontal visual analog scale (VAS) after resistive wrist dorsiflexion. The Jamar
hand dynamometer (kg) was used for evaluation of HGS<xref rid="r16" ref-type="bibr">16</xref><sup>)</sup>. The percentages of improvement in the study parameters were
recorded for each group, and the groups were compared in terms of these values.</p><p>For the ESWT group, 3X2000 shock waves with 1.6 bar intensity and 16&#x02005;Hz frequency were
applied without local anesthesia at weekly intervals using a Masterpuls MP2004 radial shock
wave therapy system (Storz Medical, Swiss). In the local steroid injection therapy group,
20&#x02005;mg methylprednisolone acetate with 1&#x02005;mL prilocaine was administered using a peppering
technique at the point with maximal tenderness in the lateral epicondyle area. All patients
used lateral epicondyle bandages during the treatment period; none of them received
analgesics, antiinflammatory drugs, or exercise program.</p><p>All statistical analyses were performed using the Statistical Package for the Social
Sciences (SPSS), version 13.0, for Windows (SPSS, Chicago, IL, USA). Continuous variables
are presented as mean&#x000b1;standard deviation [SD]. The normality of the distribution for all
variables was assessed using the Kolmogorov-Smirnov test. Patient gender and the affected
side in both groups were compared using the &#x003c7;<sup>2</sup> test. Intergroup comparisons were
made using the Student&#x02019;s t-test for normally distributed variables and the Mann-Whitney U
test for non-parametric variables. Within-group comparisons were performed using one-way
repeated measures analysis of variance or Friedman test based on data distribution. A value
of p&#x0003c;0.05 was considered statistically significant</p></sec><sec sec-type="results" id="s3"><title>RESULTS</title><p>Demographic characteristics of each group are shown in <xref rid="tbl_001" ref-type="table">Table 1</xref><table-wrap id="tbl_001" orientation="portrait" position="float"><label>Table 1.</label><caption><title>Demographic characteristics of the participants according to groups</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1"/><th valign="top" align="center" rowspan="1" colspan="1">ESWT group (n=32)</th><th valign="top" align="center" rowspan="1" colspan="1">Injection group (n=32)</th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Age (mean&#x000b1;SD) (years)</td><td align="center" valign="top" rowspan="1" colspan="1">38.7&#x000b1;9.1</td><td align="center" valign="top" rowspan="1" colspan="1">42.6&#x000b1;6.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Gender (F/M) (%) </td><td align="center" valign="top" rowspan="1" colspan="1">26/6 (81.3/18.8)</td><td align="center" valign="top" rowspan="1" colspan="1">28/4 (87.5/12.5)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Weight (kg)</td><td align="center" valign="top" rowspan="1" colspan="1">75.9&#x000b1;10.1</td><td align="center" valign="top" rowspan="1" colspan="1">76.5&#x000b1;10.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Height (m)</td><td align="center" valign="top" rowspan="1" colspan="1">1.61&#x000b1;0.05</td><td align="center" valign="top" rowspan="1" colspan="1">1.60&#x000b1;0.05</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td align="center" valign="top" rowspan="1" colspan="1"> 29&#x000b1;3.5</td><td align="center" valign="top" rowspan="1" colspan="1"> 30&#x000b1;4.6</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Disease duration (mean&#x000b1;SD) (months)</td><td align="center" valign="top" rowspan="1" colspan="1"> 8.5&#x000b1;3.5</td><td align="center" valign="top" rowspan="1" colspan="1"> 7.9&#x000b1;3.0</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Side of involvement (R/L) n (%)</td><td align="center" valign="top" rowspan="1" colspan="1">26/6 (81.3/18.8)</td><td align="center" valign="top" rowspan="1" colspan="1">28/4 (87.5/12.5)</td></tr></tbody></table></table-wrap>. There were no significant differences in age, gender, weight, height, BMI,
and affected side between the groups (p&#x0003e;0.05, for all). The mean disease duration in the
ESWT group was 8.5&#x000b1;3.5 months and in the injection group was 7.9&#x000b1;3 months.</p><p>In the injection group, the baseline mean HGS value was better than that in the ESWT group,
and the VAS score was significantly higher than that in the ESWT group (24.5&#x000b1;7.5 vs. 19&#x000b1;3,
p&#x0003c;0.001; 7.8&#x000b1;0.9 vs. 6.8&#x000b1;1.3, p=0.001, respectively). There was no difference between
groups in the baseline SF-MPQ score (19.4&#x000b1;8.4 vs. 18.7&#x000b1;4.5, p&#x0003e;0.05).</p><p>In both groups, there were statistically significant increases in the mean HGS values and
decreases in the mean VAS and SF-MPQ scores over time (p&#x0003c;0.001, for all) (<xref rid="tbl_002" ref-type="table">Table 2</xref><table-wrap id="tbl_002" orientation="portrait" position="float"><label>Table 2.</label><caption><title>Within-group comparison of HGS, VAS score, and SF-MPQ score according to the
follow-up duration</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" align="left" colspan="1"/><th rowspan="3" align="center" valign="middle" colspan="1">Baseline</th><th align="center" rowspan="1" colspan="1">Post-treatment </th><th align="center" rowspan="1" colspan="1">Post-treatment</th></tr><tr><th colspan="2" rowspan="1"><hr/></th></tr><tr><th align="center" rowspan="1" colspan="1">4th week</th><th align="center" rowspan="1" colspan="1">12th week</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">ESWT group</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">HGS (kg)*</td><td align="center" rowspan="1" colspan="1"> 19&#x000b1;3.0</td><td align="center" rowspan="1" colspan="1"> 24&#x000b1;3.5</td><td align="center" rowspan="1" colspan="1">28.8&#x000b1;1.6</td></tr><tr><td align="left" rowspan="1" colspan="1">VAS*</td><td align="center" rowspan="1" colspan="1"> 6.8&#x000b1;1.3</td><td align="center" rowspan="1" colspan="1"> 2.1&#x000b1;0.9</td><td align="center" rowspan="1" colspan="1"> 0.7&#x000b1;0.6</td></tr><tr><td align="left" rowspan="1" colspan="1">SF-MPQ*</td><td align="center" rowspan="1" colspan="1">18.4&#x000b1;8.4</td><td align="center" rowspan="1" colspan="1"> 9.2&#x000b1;4.7</td><td align="center" rowspan="1" colspan="1"> 5.1&#x000b1;2.5</td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/><td align="left" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Injection group</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">HGS (kg)*</td><td align="center" rowspan="1" colspan="1">24.5&#x000b1;7.5</td><td align="center" rowspan="1" colspan="1">29.2&#x000b1; 8.5</td><td align="center" rowspan="1" colspan="1">30.7&#x000b1;8.4</td></tr><tr><td align="left" rowspan="1" colspan="1">VAS*</td><td align="center" rowspan="1" colspan="1"> 7.8&#x000b1;0.9</td><td align="center" rowspan="1" colspan="1"> 3.1&#x000b1;1.5</td><td align="center" rowspan="1" colspan="1"> 2.4&#x000b1;1.6</td></tr><tr><td align="left" rowspan="1" colspan="1">SF-MPQ*</td><td align="center" rowspan="1" colspan="1">18.7&#x000b1;4.5</td><td align="center" rowspan="1" colspan="1"> 9.5&#x000b1;3.3</td><td align="center" rowspan="1" colspan="1"> 7.1&#x000b1;3.4</td></tr></tbody></table><table-wrap-foot><p>Values are expressed as mean&#x000b1;standard deviation. *p&#x0003c;0.01</p><p>ESWT: extracorporeal shock wave therapy; HGS: hand grip strength; VAS: visual
analog scale; SF-MPQ: short-form McGill pain questionnaire</p></table-wrap-foot></table-wrap>). The percentages of improvements in the study parameters for
each group during the follow-up period are shown in <xref rid="tbl_003" ref-type="table">Table 3</xref><table-wrap id="tbl_003" orientation="portrait" position="float"><label>Table 3.</label><caption><title>Comparison of groups according to the percentage of improvement in HGS, VAS
score, and SF-MPQ score during the follow-up period</title></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3" align="left" colspan="1"/><th align="center" rowspan="1" colspan="1">ESWT group</th><th align="center" rowspan="1" colspan="1">Injection group</th></tr><tr><th colspan="2" rowspan="1"><hr/></th></tr><tr><th align="center" rowspan="1" colspan="1">(n=32)</th><th align="center" rowspan="1" colspan="1">(n=32)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Improvement in HGS at 4th week </td><td align="center" rowspan="1" colspan="1">27.6&#x000b1;13.9 </td><td align="center" rowspan="1" colspan="1">20.5&#x000b1;15.2</td></tr><tr><td align="left" rowspan="1" colspan="1">Improvement in HGS at 12th week*</td><td align="center" rowspan="1" colspan="1">55.1&#x000b1;20.6</td><td align="center" rowspan="1" colspan="1">28.5&#x000b1;21.9</td></tr><tr><td align="left" rowspan="1" colspan="1">Improvement in HGS between 4th and 12th weeks*</td><td align="center" rowspan="1" colspan="1">22.2&#x000b1;13.6</td><td align="center" rowspan="1" colspan="1"> 7.5&#x000b1;9.6</td></tr><tr><td align="left" rowspan="1" colspan="1">Improvement in VAS at 4th week*</td><td align="center" rowspan="1" colspan="1">70.1&#x000b1;11.0</td><td align="center" rowspan="1" colspan="1">59.8&#x000b1;18.3</td></tr><tr><td align="left" rowspan="1" colspan="1">Improvement in VAS at 12th week*</td><td align="center" rowspan="1" colspan="1">90.4&#x000b1;8.9</td><td align="center" rowspan="1" colspan="1">69.7&#x000b1;19.2 </td></tr><tr><td align="left" rowspan="1" colspan="1">Improvement in VAS between the 4th and 12th weeks*</td><td align="center" rowspan="1" colspan="1">68.9&#x000b1;27.6 </td><td align="center" rowspan="1" colspan="1">32.4&#x000b1;36.01</td></tr><tr><td align="left" rowspan="1" colspan="1">Improvement in SF-MPQ at 4th week</td><td align="center" rowspan="1" colspan="1">50.9&#x000b1;12.4</td><td align="center" rowspan="1" colspan="1">49.3&#x000b1;11.7</td></tr><tr><td align="left" rowspan="1" colspan="1">Improvement in VAS at 12th week*</td><td align="center" rowspan="1" colspan="1">70.8&#x000b1;10.9 </td><td align="center" rowspan="1" colspan="1">62.6&#x000b1;13.3 </td></tr><tr><td align="left" rowspan="1" colspan="1">Improvement in VAS between the 4th and 12th weeks*</td><td align="center" rowspan="1" colspan="1">44.6&#x000b1;17.9</td><td align="center" rowspan="1" colspan="1">26.4&#x000b1;21.2</td></tr></tbody></table><table-wrap-foot><p>Values (%) are expressed as mean&#x000b1;standard deviation. *p &#x0003c;0.01</p><p>ESWT: extracorporeal shock wave therapy; HGS: hand grip strength; VAS: visual analog
scale; SF-MPQ: short-form McGill pain questionnaire</p></table-wrap-foot></table-wrap>. There was no statistically significant difference in the percentage of
improvement in HGS and the SF-MPQ score between groups at 4 weeks post-treatment (p=0.077,
p=0.584), whereas the ESWT group showed better results in the VAS score than the injection
group (p=0.009). The percentages of improvements in HGS, VAS score, and SF-MPQ score were
higher in the ESWT group than in the steroid injection group at 12 weeks post-treatment
(p&#x0003c;0.001, p&#x0003c;0.001, p=0.009, respectively). Additionally, the percentages of
improvements in HGS, VAS score, and SF-MPQ score between 4 weeks and 12 weeks post-treatment
in the ESWT group were higher than those in the steroid injection group (p&#x0003c;0.001,
p&#x0003c;0.001, p=0.001, respectively).</p></sec><sec sec-type="discussion" id="s4"><title>DISCUSSION</title><p>In our study, the effectiveness of ESWT and local corticosteroid injection therapy was
compared between groups and within groups during the 12-week follow-up period. Both the ESWT
and corticosteroid injection treatment showed statistically significant improvements in HGS,
VAS score, and SF-MPQ score over time compared to baseline values. Numerous treatments used
in clinical practice for management of LE have been evaluated in the literature, but there
has been no consensus on the best treatment. Local glucocorticosteroid injections have been
used formerly in patients with LE. A systematic review by Smidt et al. demonstrated
statistically significant differences in terms of pain, global improvement, and grip
strength in the corticosteroid injection group compared to placebo, local anesthetic, and
conservative treatment including nonsteroidal anti-inflammatory drugs, elbow support, and
physical therapy, but no beneficial effects were demonstrated at the intermediate and
long-term follow-up<xref rid="r17" ref-type="bibr">17</xref><sup>)</sup>. Similar results
also have been reported by others in the literature<xref rid="r7" ref-type="bibr">7</xref>,
<xref rid="r18" ref-type="bibr">18</xref>,<xref rid="r19" ref-type="bibr">19</xref>,<xref rid="r20" ref-type="bibr">20</xref><sup>)</sup>. On the other hand, 2 other studies found
no significant differences in the VAS and functional scores, even in the short-term, in the
steroid injection group compared to the placebo injection group<xref rid="r21" ref-type="bibr">21</xref>, <xref rid="r22" ref-type="bibr">22</xref><sup>)</sup>. In our study,
post-treatment improvements in the VAS score, HGS, and the SF-MPQ score in the steroid
injection group were statistically significant at both 4 and 12 weeks post-treatment.</p><p>In the present study, the effectiveness of ESWT compared to the steroid injection therapy
was evaluated. There was no statistically significant difference in the improvement in HGS
and SF-MPQ score between groups at 4 weeks, whereas the improvements in HGS, VAS score, and
SF-MPQ score were higher in the ESWT group than in the injection group at 12 weeks. In
addition, the ESWT group showed better improvement in HGS, VAS score, and SF-MPQ score
between the 4th and 12th week post-treatment than the injection group, indicating the
greater beneficial effects of ESWT than the steroid injection at the long-term follow-up. A
study by Speed et al.<xref rid="r23" ref-type="bibr">23</xref><sup>)</sup> found no
difference in VAS score between ESWT and sham therapy at 3 months. In this study, the
authors concluded that there was no evidence of added benefit of treatment compared to sham
therapy other than a significant placebo effect of moderate dose ESWT. Melikyan et al.<xref rid="r24" ref-type="bibr">24</xref><sup>)</sup> also reported that the differences in HGS,
pain, and functional impairment between the ESWT and control groups were not statistically
significant. By contrast, statistically significant decreases in pain and functional
impairment, and an increase in HGS were demonstrated in a 6-month follow-up study by Spacca
et al<xref rid="r11" ref-type="bibr">11</xref><sup>)</sup>. Additionally, Pettrone and
McCall<xref rid="r10" ref-type="bibr">10</xref><sup>)</sup> reported statistically
significant improvement in pain and functional activity score with ESWT compared to sham
therapy. Previously, some studies have compared the effectiveness of local corticosteroid
injection and ESWT. In a 6-month follow-up study by Crowther et al.<xref rid="r25" ref-type="bibr">25</xref><sup>)</sup>, it was found that local corticosteroid injection was more
successful and 100 times less expensive than ESWT in the treatment of LE. Three sessions of
ESWT with 2000 shock waves at weekly intervals were used in their study. G&#x000fc;nd&#x000fc;z et al.<xref rid="r26" ref-type="bibr">26</xref><sup>)</sup> also compared the therapeutic effects of
physical therapy modalities, local corticosteroid injection, and ESWT in LE and found that
all the therapies had favorable effects on pain and grip strength in the early period of LE
treatment. Changes in the VAS score and grip strength of the patients at follow-up were not
statistically significant among the treatment groups in their study. In addition, the ESWT
protocol consisting of 10X500 shock waves with 1.4 bar intensity and 4.0&#x02005;Hz frequency
administered at a 1-day interval between sessions differed from the protocol used in our
study. Lee et al.<xref rid="r27" ref-type="bibr">27</xref><sup>)</sup> demonstrated superior
symptom relief and subjective satisfaction levels at the beginning of the treatment in the
local steroid injection group compared to the ESWT group. However, there were no significant
differences in the clinical improvement between the groups afterwards, and the subjective
satisfaction level with ESWT was even higher. Since their study involved a small number of
patients with LE (only 5 patients), the results regarding the effectiveness of ESWT in LE
treatment are considered inconclusive.</p><p>Our study has some limitations. A placebo group was not included in this study.
Additionally, the follow-up period was short, and long-term effectiveness was therefore not
assessed. In addition, the use of a lateral epicondyle support may have affected the results
of our study. In conclusion, our study showed that both the ESWT and local steroid injection
were effective in the treatment of LE, and the improvement in HGS was greater in the ESWT
group than in the injection group at the long-term follow-up. However, further follow-up
studies involving large samples are required to obtain sufficient evidence regarding
effective treatment of LE.</p></sec></body><back><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><person-group><name><surname>Taspinar</surname><given-names>O</given-names></name><name><surname>Kepekci</surname><given-names>M</given-names></name><name><surname>Ozaras</surname><given-names>N</given-names></name><etal>et al.</etal></person-group>: <article-title>Upper extremity problems in doner kebab
masters</article-title>. <source>J Phys Ther Sci</source>, <year>2014</year>,
<volume>26</volume>: <fpage>1433</fpage>&#x02013;<lpage>1436</lpage>. <pub-id pub-id-type="pmid">25276030</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><person-group><name><surname>Judson</surname><given-names>CH</given-names></name><name><surname>Wolf</surname><given-names>JM</given-names></name></person-group>: <article-title>Lateral epicondylitis: review of injection
therapies</article-title>. <source>Orthop Clin North Am</source>, <year>2013</year>,
<volume>44</volume>: <fpage>615</fpage>&#x02013;<lpage>623</lpage>. <pub-id pub-id-type="pmid">24095076</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="book"><person-group><name><surname>Wilk</surname><given-names>K</given-names></name><name><surname>Andrews</surname><given-names>JR</given-names></name></person-group>: Elbow Injuries. In: Clinical Orthopaedic Rehabilitation. Edited by SB
Brotzman, KE Wilk. Philadelphia: Mosby, <year>2003</year>, pp 85&#x02013;123.</mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><person-group><name><surname>Pitzer</surname><given-names>ME</given-names></name><name><surname>Seidenberg</surname><given-names>PH</given-names></name><name><surname>Bader</surname><given-names>DA</given-names></name></person-group>: <article-title>Elbow tendinopathy</article-title>. <source>Med Clin North
Am</source>, <year>2014</year>, <volume>98</volume>: <fpage>833</fpage>&#x02013;<lpage>849,
xiii</lpage>. <pub-id pub-id-type="pmid">24994055</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><person-group><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Ko</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>W</given-names></name></person-group>: <article-title>Changes in pain, dysfunction, and grip strength of
patients with acute lateral epicondylitis caused by frequency of physical therapy: a
randomized controlled trial</article-title>. <source>J Phys Ther Sci</source>,
<year>2014</year>, <volume>26</volume>: <fpage>1037</fpage>&#x02013;<lpage>1040</lpage>.
<pub-id pub-id-type="pmid">25140091</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><person-group><name><surname>Tosti</surname><given-names>R</given-names></name><name><surname>Jennings</surname><given-names>J</given-names></name><name><surname>Sewards</surname><given-names>JM</given-names></name></person-group>: <article-title>Lateral epicondylitis of the elbow</article-title>.
<source>Am J Med</source>, <year>2013</year>, <volume>126</volume>:
<fpage>357.e1</fpage>&#x02013;<lpage>357.e6</lpage>. <pub-id pub-id-type="pmid">23398951</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><person-group><name><surname>Krogh</surname><given-names>TP</given-names></name><name><surname>Bartels</surname><given-names>EM</given-names></name><name><surname>Ellingsen</surname><given-names>T</given-names></name><etal>et al.</etal></person-group>: <article-title>Comparative effectiveness of injection therapies in
lateral epicondylitis: a systematic review and network meta-analysis of randomized
controlled trials</article-title>. <source>Am J Sports Med</source>, <year>2013</year>,
<volume>41</volume>: <fpage>1435</fpage>&#x02013;<lpage>1446</lpage>. <pub-id pub-id-type="pmid">22972856</pub-id></mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><person-group><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Lee</surname><given-names>D</given-names></name><name><surname>Park</surname><given-names>J</given-names></name></person-group>: <article-title>Effects of extracorporeal shockwave therapy on patients
with chronic low back pain and their dynamic balance ability</article-title>. <source>J
Phys Ther Sci</source>, <year>2014</year>, <volume>26</volume>:
<fpage>7</fpage>&#x02013;<lpage>10</lpage>. <pub-id pub-id-type="pmid">24567665</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><person-group><name><surname>Rompe</surname><given-names>JD</given-names></name><name><surname>Hope</surname><given-names>C</given-names></name><name><surname>K&#x000fc;llmer</surname><given-names>K</given-names></name><etal>et al.</etal></person-group>: <article-title>Analgesic effect of extracorporeal shock-wave therapy on
chronic tennis elbow</article-title>. <source>J Bone Joint Surg Br</source>,
<year>1996</year>, <volume>78</volume>: <fpage>233</fpage>&#x02013;<lpage>237</lpage>.
<pub-id pub-id-type="pmid">8666632</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><person-group><name><surname>Pettrone</surname><given-names>FA</given-names></name><name><surname>McCall</surname><given-names>BR</given-names></name></person-group>: <article-title>Extracorporeal shock wave therapy without local anesthesia
for chronic lateral epicondylitis</article-title>. <source>J Bone Joint Surg
Am</source>, <year>2005</year>, <volume>87</volume>:
<fpage>1297</fpage>&#x02013;<lpage>1304</lpage>. <pub-id pub-id-type="pmid">15930540</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><person-group><name><surname>Spacca</surname><given-names>G</given-names></name><name><surname>Necozione</surname><given-names>S</given-names></name><name><surname>Cacchio</surname><given-names>A</given-names></name></person-group>: <article-title>Radial shock wave therapy for lateral epicondylitis: a
prospective randomised controlled single-blind study</article-title>. <source>Eura
Medicophys</source>, <year>2005</year>, <volume>41</volume>:
<fpage>17</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="pmid">16175767</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><person-group><name><surname>Buchbinder</surname><given-names>R</given-names></name><name><surname>Green</surname><given-names>SE</given-names></name><name><surname>Youd</surname><given-names>JM</given-names></name><etal>et al.</etal></person-group>: <article-title>Systematic review of the efficacy and safety of shock wave
therapy for lateral elbow pain</article-title>. <source>J Rheumatol</source>,
<year>2006</year>, <volume>33</volume>: <fpage>1351</fpage>&#x02013;<lpage>1363</lpage>.
<pub-id pub-id-type="pmid">16821270</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="book"><person-group><name><surname>Regan</surname><given-names>W</given-names></name><name><surname>Grondin</surname><given-names>P</given-names></name><name><surname>Morrey</surname><given-names>BF</given-names></name></person-group>: Lateral epicondylitis (tennis elbow). In: DeLee and Drez&#x02019;s Orthopaedic
Sports Medicine. Edited by J DeLee, D Drez, M Miller. New York: Elsevier,
<year>2009</year>, pp 1197&#x02013;1204.</mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><person-group><name><surname>Melzack</surname><given-names>R</given-names></name></person-group>: <article-title>The short-form McGill Pain Questionnaire</article-title>.
<source>Pain</source>, <year>1987</year>, <volume>30</volume>:
<fpage>191</fpage>&#x02013;<lpage>197</lpage>. <pub-id pub-id-type="pmid">3670870</pub-id></mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><person-group><name><surname>Yakut</surname><given-names>Y</given-names></name><name><surname>Yakut</surname><given-names>E</given-names></name><name><surname>Bayar</surname><given-names>K</given-names></name><etal>et al.</etal></person-group>: <article-title>Reliability and validity of the Turkish version short-form
McGill pain questionnaire in patients with rheumatoid arthritis</article-title>.
<source>Clin Rheumatol</source>, <year>2007</year>, <volume>26</volume>:
<fpage>1083</fpage>&#x02013;<lpage>1087</lpage>. <pub-id pub-id-type="pmid">17106618</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><person-group><name><surname>Haidar</surname><given-names>SG</given-names></name><name><surname>Kumar</surname><given-names>D</given-names></name><name><surname>Bassi</surname><given-names>RS</given-names></name><etal>et al.</etal></person-group>: <article-title>Average versus maximum grip strength: which is more
consistent?</article-title><source>J Hand Surg [Br]</source>, <year>2004</year>,
<volume>29</volume>: <fpage>82</fpage>&#x02013;<lpage>84</lpage>. </mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><person-group><name><surname>Smidt</surname><given-names>N</given-names></name><name><surname>Assendelft</surname><given-names>WJ</given-names></name><name><surname>van der Windt</surname><given-names>DA</given-names></name><etal>et al.</etal></person-group>: <article-title>Corticosteroid injections for lateral epicondylitis: a
systematic review</article-title>. <source>Pain</source>, <year>2002</year>,
<volume>96</volume>: <fpage>23</fpage>&#x02013;<lpage>40</lpage>. <pub-id pub-id-type="pmid">11932058</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><person-group><name><surname>Hay</surname><given-names>EM</given-names></name><name><surname>Paterson</surname><given-names>SM</given-names></name><name><surname>Lewis</surname><given-names>M</given-names></name><etal>et al.</etal></person-group>: <article-title>Pragmatic randomised controlled trial of local
corticosteroid injection and naproxen for treatment of lateral epicondylitis of elbow in
primary care</article-title>. <source>BMJ</source>, <year>1999</year>,
<volume>319</volume>: <fpage>964</fpage>&#x02013;<lpage>968</lpage>. <pub-id pub-id-type="pmid">10514160</pub-id></mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><person-group><name><surname>Smidt</surname><given-names>N</given-names></name><name><surname>van der Windt</surname><given-names>DA</given-names></name><name><surname>Assendelft</surname><given-names>WJ</given-names></name><etal>et al.</etal></person-group>: <article-title>Corticosteroid injections, physiotherapy, or a
wait-and-see policy for lateral epicondylitis: a randomised controlled
trial</article-title>. <source>Lancet</source>, <year>2002</year>, <volume>359</volume>:
<fpage>657</fpage>&#x02013;<lpage>662</lpage>. <pub-id pub-id-type="pmid">11879861</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><person-group><name><surname>Gaujoux-Viala</surname><given-names>C</given-names></name><name><surname>Dougados</surname><given-names>M</given-names></name><name><surname>Gossec</surname><given-names>L</given-names></name></person-group>: <article-title>Efficacy and safety of steroid injections for shoulder and
elbow tendonitis: a meta-analysis of randomised controlled trials</article-title>.
<source>Ann Rheum Dis</source>, <year>2009</year>, <volume>68</volume>:
<fpage>1843</fpage>&#x02013;<lpage>1849</lpage>. <pub-id pub-id-type="pmid">19054817</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><person-group><name><surname>Lindenhovius</surname><given-names>A</given-names></name><name><surname>Henket</surname><given-names>M</given-names></name><name><surname>Gilligan</surname><given-names>BP</given-names></name><etal>et al.</etal></person-group>: <article-title>Injection of dexamethasone versus placebo for lateral
elbow pain: a prospective, double-blind, randomized clinical trial</article-title>.
<source>J Hand Surg Am</source>, <year>2008</year>, <volume>33</volume>:
<fpage>909</fpage>&#x02013;<lpage>919</lpage>. <pub-id pub-id-type="pmid">18656765</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><person-group><name><surname>Newcomer</surname><given-names>KL</given-names></name><name><surname>Laskowski</surname><given-names>ER</given-names></name><name><surname>Idank</surname><given-names>DM</given-names></name><etal>et al.</etal></person-group>: <article-title>Corticosteroid injection in early treatment of lateral
epicondylitis</article-title>. <source>Clin J Sport Med</source>, <year>2001</year>,
<volume>11</volume>: <fpage>214</fpage>&#x02013;<lpage>222</lpage>. <pub-id pub-id-type="pmid">11753057</pub-id></mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><person-group><name><surname>Speed</surname><given-names>CA</given-names></name><name><surname>Nichols</surname><given-names>D</given-names></name><name><surname>Richards</surname><given-names>C</given-names></name><etal>et al.</etal></person-group>: <article-title>Extracorporeal shock wave therapy for lateral
epicondylitis&#x02014;a double blind randomised controlled trial</article-title>. <source>J
Orthop Res</source>, <year>2002</year>, <volume>20</volume>:
<fpage>895</fpage>&#x02013;<lpage>898</lpage>. <pub-id pub-id-type="pmid">12382950</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><person-group><name><surname>Melikyan</surname><given-names>EY</given-names></name><name><surname>Shahin</surname><given-names>E</given-names></name><name><surname>Miles</surname><given-names>J</given-names></name><etal>et al.</etal></person-group>: <article-title>Extracorporeal shock-wave treatment for tennis elbow. A
randomised double-blind study</article-title>. <source>J Bone Joint Surg Br</source>,
<year>2003</year>, <volume>85</volume>: <fpage>852</fpage>&#x02013;<lpage>855</lpage>.
<pub-id pub-id-type="pmid">12931804</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><person-group><name><surname>Crowther</surname><given-names>MA</given-names></name><name><surname>Bannister</surname><given-names>GC</given-names></name><name><surname>Huma</surname><given-names>H</given-names></name><etal>et al.</etal></person-group>: <article-title>A prospective, randomised study to compare extracorporeal
shock-wave therapy and injection of steroid for the treatment of tennis
elbow</article-title>. <source>J Bone Joint Surg Br</source>, <year>2002</year>,
<volume>84</volume>: <fpage>678</fpage>&#x02013;<lpage>679</lpage>. <pub-id pub-id-type="pmid">12188483</pub-id></mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="journal"><person-group><name><surname>G&#x000fc;nd&#x000fc;z</surname><given-names>R</given-names></name><name><surname>Malas</surname><given-names>F&#x000dc;</given-names></name><name><surname>Borman</surname><given-names>P</given-names></name><etal>et al.</etal></person-group>: <article-title>Physical therapy, corticosteroid injection, and
extracorporeal shock wave treatment in lateral epicondylitis. Clinical and
ultrasonographical comparison</article-title>. <source>Clin Rheumatol</source>,
<year>2012</year>, <volume>31</volume>: <fpage>807</fpage>&#x02013;<lpage>812</lpage>.
<pub-id pub-id-type="pmid">22278162</pub-id></mixed-citation></ref><ref id="r27"><label>27</label><mixed-citation publication-type="journal"><person-group><name><surname>Lee</surname><given-names>SS</given-names></name><name><surname>Kang</surname><given-names>S</given-names></name><name><surname>Park</surname><given-names>NK</given-names></name><etal>et al.</etal></person-group>: <article-title>Effectiveness of initial extracorporeal shock wave therapy
on the newly diagnosed lateral or medial epicondylitis</article-title>. <source>Ann
Rehabil Med</source>, <year>2012</year>, <volume>36</volume>:
<fpage>681</fpage>&#x02013;<lpage>687</lpage>. <pub-id pub-id-type="pmid">23185733</pub-id></mixed-citation></ref></ref-list></back></article>